Company profile
Ticker
MYRX
Exchange
Website
CEO
Mr. Jonathan M. Couchman CFA
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Myriad Pharmaceuticals, Inc.
SEC CIK
Corporate docs
IRS number
263996918
MYRX stock data
Latest filings (excl ownership)
15-12B
Securities registration termination
31 Jul 13
10-K/A
2013 FY
Annual report (amended)
26 Jul 13
10-K
2013 FY
Annual report
17 Jul 13
AW
Withdrawal of amendment
15 Jul 13
EFFECT
Notice of effectiveness
11 Jul 13
EFFECT
Notice of effectiveness
11 Jul 13
POS AM
Prospectus update (post-effective amendment)
11 Jul 13
POS AM
Prospectus update (post-effective amendment)
11 Jul 13
S-3/A
Shelf registration (amended)
2 Jul 13
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Jul 13
Latest ownership filings
4
JONATHAN COUCHMAN
17 Aug 21
4
JONATHAN COUCHMAN
26 Aug 20
4
JONATHAN COUCHMAN
6 Aug 20
3
Brian James Harper
6 Aug 20
4/A
JONATHAN COUCHMAN
31 Mar 20
3
ENZON PHARMACEUTICALS, INC.
31 Mar 20
SC 13D
Xstelos Holdings, Inc.
11 Mar 13
SC 13D/A
ICS OPPORTUNITIES, LTD.
27 Feb 13
SC 13D/A
First Eagle Investment Management, LLC
13 Nov 12
SC 13D/A
First Eagle Investment Management, LLC
7 Nov 12
Institutional ownership, Q2 2022
0.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 1 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 36.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Captrust Financial Advisors | 36.00 | $0.00 |